Following massive progress on the Woolly Mammoth and Tasmanian tiger, Colossal launches Avian Genomics Group to continue groundbreaking de-extinction pursuits Dr. Beth Shapiro, Ph.D. (Lead Paleogeneticist and Colossal Scientific Advisory Board Member) and Ben Lamm (Colossal Co-Founder and CEO). Image courtesy of Colossal Biosciences. ********************************************************** DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world’s first de-extinction company, has today announced an oversubscribed $150M Series B financing led by United States Innovative Technology Fund (“USIT”), with participation from Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca Brands, Peak 6, BOLD Capital, and Jazz Ventures, among others. Since launching in September 2021,...